Trial Profile
A Cohort Study of Tenofovir on Blocking HBV Intrauterine Infection
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2022
Price :
$35
*
At a glance
- Drugs Tenofovir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 12 May 2020 Planned End Date changed from 1 Dec 2019 to 1 Dec 2022.
- 12 May 2020 Planned primary completion date changed from 1 Dec 2019 to 1 Dec 2022.
- 13 May 2019 Status changed from active, no longer recruiting to recruiting.